MAGLIO, ANGELANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 513
EU - Europa 219
AS - Asia 70
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 805
Nazione #
US - Stati Uniti d'America 512
IT - Italia 145
IE - Irlanda 34
CN - Cina 20
VN - Vietnam 17
IN - India 15
TR - Turchia 12
UA - Ucraina 9
ES - Italia 8
DE - Germania 6
CZ - Repubblica Ceca 4
SE - Svezia 4
FI - Finlandia 3
FR - Francia 3
NP - Nepal 3
KW - Kuwait 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CA - Canada 1
EU - Europa 1
GB - Regno Unito 1
IL - Israele 1
RO - Romania 1
Totale 805
Città #
Chandler 132
Ann Arbor 70
Princeton 60
Ashburn 54
Naples 37
Dublin 28
Woodbridge 24
Jacksonville 18
Salerno 18
Dong Ket 17
Pune 15
Izmir 12
Wilmington 8
Rome 7
Seattle 7
Acerra 6
Beijing 6
Dearborn 6
Houston 6
Andover 5
Boardman 5
Los Angeles 5
Milan 5
Redwood City 5
Brno 4
Grammichele 4
Nanjing 4
Cambridge 3
Kathmandu 3
Monte Di Procida 3
Munich 3
New York 3
Osio Sotto 3
Arzano 2
Bari 2
Bologna 2
Campi Bisenzio 2
Hanover 2
Kuwait City 2
Norwalk 2
Pellezzano 2
San Giorgio a Cremano 2
Shenyang 2
Arienzo 1
Bedford 1
Bucharest 1
Castel San Giorgio 1
Catanzaro 1
Cava 1
Changsha 1
Chicago 1
Chiesina Uzzanese 1
Cinisello Balsamo 1
Fairfield 1
Ferrara 1
Fortaleza 1
Hebei 1
Helsinki 1
Indiana 1
Jiaxing 1
Jinan 1
Kunming 1
Lappeenranta 1
Laurel 1
Mestre 1
Monteforte Irpino 1
Montreuil 1
Nanchang 1
Napoli 1
Palermo 1
Recale 1
San Diego 1
Sant'antimo 1
Siena 1
Sofia 1
Sydney 1
Tel Aviv 1
Tianjin 1
Toronto 1
Walnut 1
Xian 1
Totale 644
Nome #
Age as a risk factor in the occurrence of pneumothorax after transthoracic fine needle biopsy: our experience 92
Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer. 74
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 68
SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease 54
Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral 44
Phenotyping severe asthma: a rationale for biologic therapy 41
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 38
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 36
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 35
Novel Biological Therapies for Severe Asthma Endotypes 33
Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β 32
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 30
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 29
Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up 27
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 26
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 25
Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β 22
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 21
Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives 18
Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up 18
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 18
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 16
THE MANY FACES OF COVID-19: ORGANIZING PNEUMONIA (OP) PATTERN HRCT FEATURES 15
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 14
Tezepelumab: A potential new biological therapy for severe refractory asthma 14
DPO: DIFFUSE PULMONARY OSSIFICATION - A DIAGNOSTIC CHALLENGE 6
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 3
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 2
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy 1
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 1
Design per una nuova cultura della prevenzione 1
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 1
Compendio di malattie dell'apparato respiratorio 1
Totale 856
Categoria #
all - tutte 3.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 3 16 5
2019/202044 11 3 5 0 2 0 2 3 2 4 11 1
2020/202171 2 5 5 2 20 5 3 1 2 3 4 19
2021/2022120 0 0 3 1 0 13 15 3 10 5 22 48
2022/2023300 19 42 28 39 22 54 9 26 25 6 20 10
2023/2024172 17 15 9 12 6 43 12 41 4 13 0 0
Totale 856